In contrast, during the chronic recovery phase, “anti‐inflammatory” (M2‐type) microglia aid in hematoma resolution and tissue repair by phagocytosing cellular debris and engaging in receptor‐mediated clearance via CD163, CD36, and CD47 [54]. This evidence concerns the gene CD163 and hematoma.